KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 71 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,005 | +7.9% | 25,338 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $226,044 | +15.9% | 25,116 | +87.0% | 0.00% | 0.0% |
| Q3 2022 | $195,000 | +36.4% | 13,433 | -7.7% | 0.00% | +100.0% |
| Q2 2022 | $143,000 | -61.6% | 14,561 | -42.3% | 0.00% | -75.0% |
| Q1 2022 | $372,000 | -0.5% | 25,219 | -10.8% | 0.00% | 0.0% |
| Q4 2021 | $374,000 | +30.3% | 28,274 | +23.9% | 0.00% | 0.0% |
| Q3 2020 | $287,000 | -2.7% | 22,822 | -6.3% | 0.00% | 0.0% |
| Q2 2020 | $295,000 | +19.0% | 24,350 | -24.8% | 0.00% | 0.0% |
| Q1 2020 | $248,000 | -61.5% | 32,390 | -10.4% | 0.00% | -20.0% |
| Q4 2019 | $644,000 | – | 36,164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |